Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1953 3
1954 1
1956 2
1958 2
1959 1
1960 1
1961 7
1962 3
1963 5
1964 5
1965 6
1966 8
1967 9
1968 12
1969 11
1970 11
1971 20
1972 23
1973 13
1974 17
1975 11
1976 13
1977 14
1978 17
1979 18
1980 27
1981 29
1982 24
1983 49
1984 31
1985 32
1986 29
1987 36
1988 41
1989 37
1990 38
1991 43
1992 42
1993 33
1994 32
1995 50
1996 40
1997 43
1998 57
1999 71
2000 74
2001 56
2002 71
2003 85
2004 74
2005 93
2006 79
2007 114
2008 105
2009 102
2010 106
2011 117
2012 122
2013 128
2014 119
2015 133
2016 156
2017 175
2018 161
2019 159
2020 180
2021 179
2022 179
2023 164
2024 111

Text availability

Article attribute

Article type

Publication date

Search Results

3,711 results

Results by year

Filters applied: . Clear all
Page 1
Avascular spaces in radical hysterectomy.
Zapardiel I, Ceccaroni M, Minig L, Halaska MJ, Fujii S. Zapardiel I, et al. Among authors: fujii s. Int J Gynecol Cancer. 2023 Feb 6;33(2):285-292. doi: 10.1136/ijgc-2022-004071. Int J Gynecol Cancer. 2023. PMID: 36581489 Review.
Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial.
Nakamura Y, Okamoto W, Kato T, Esaki T, Kato K, Komatsu Y, Yuki S, Masuishi T, Nishina T, Ebi H, Sawada K, Taniguchi H, Fuse N, Nomura S, Fukui M, Matsuda S, Sakamoto Y, Uchigata H, Kitajima K, Kuramoto N, Asakawa T, Olsen S, Odegaard JI, Sato A, Fujii S, Ohtsu A, Yoshino T. Nakamura Y, et al. Among authors: fujii s. Nat Med. 2021 Nov;27(11):1899-1903. doi: 10.1038/s41591-021-01553-w. Epub 2021 Nov 11. Nat Med. 2021. PMID: 34764486 Free PMC article. Clinical Trial.
Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
Matsumoto K, Oda K, Shoji K, Hanai Y, Takahashi Y, Fujii S, Hamada Y, Kimura T, Mayumi T, Ueda T, Nakajima K, Takesue Y. Matsumoto K, et al. Among authors: fujii s. Pharmaceutics. 2022 Feb 23;14(3):489. doi: 10.3390/pharmaceutics14030489. Pharmaceutics. 2022. PMID: 35335866 Free PMC article. Review.
Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
Takesue Y, Hanai Y, Oda K, Hamada Y, Ueda T, Mayumi T, Matsumoto K, Fujii S, Takahashi Y, Miyazaki Y, Kimura T; Japanese Antimicrobial Therapeutic Drug Monitoring Guideline Committee. Takesue Y, et al. Among authors: fujii s. Clin Ther. 2022 Dec;44(12):1604-1623. doi: 10.1016/j.clinthera.2022.10.005. Epub 2022 Nov 22. Clin Ther. 2022. PMID: 36424314 Free article. Review.
SHI family transcription factors regulate an interspecific barrier.
Fujii S, Yamamoto E, Ito S, Tangpranomkorn S, Kimura Y, Miura H, Yamaguchi N, Kato Y, Niidome M, Yoshida A, Shimosato-Asano H, Wada Y, Ito T, Takayama S. Fujii S, et al. Nat Plants. 2023 Nov;9(11):1862-1873. doi: 10.1038/s41477-023-01535-5. Epub 2023 Oct 5. Nat Plants. 2023. PMID: 37798337
Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.
Jikuya R, Johnson TA, Maejima K, An J, Ju YS, Lee H, Ha K, Song W, Kim Y, Okawa Y, Sasagawa S, Kanazashi Y, Fujita M, Imoto S, Mitome T, Ohtake S, Noguchi G, Kawaura S, Iribe Y, Aomori K, Tatenuma T, Komeya M, Ito H, Ito Y, Muraoka K, Furuya M, Kato I, Fujii S, Hamanoue H, Tamura T, Baba M, Suda T, Kodama T, Makiyama K, Yao M, Shuch BM, Ricketts CJ, Schmidt LS, Linehan WM, Nakagawa H, Hasumi H. Jikuya R, et al. Among authors: fujii s. EBioMedicine. 2023 Jun;92:104596. doi: 10.1016/j.ebiom.2023.104596. Epub 2023 May 12. EBioMedicine. 2023. PMID: 37182269 Free PMC article.
Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study.
Urata T, Naoi Y, Jiang A, Boyle M, Sunami K, Imai T, Nawa Y, Hiramatsu Y, Yamamoto K, Fujii S, Yoshida I, Yano T, Chijimatsu R, Murakami H, Ikeuchi K, Kobayashi H, Tani K, Ujiie H, Inoue H, Tomida S, Yamamoto A, Kondo T, Fujiwara H, Asada N, Nishimori H, Fujii K, Fujii N, Matsuoka KI, Sawada K, Momose S, Tamaru JI, Nishikori A, Sato Y, Yoshino T, Maeda Y, Scott DW, Ennishi D. Urata T, et al. Among authors: fujii s. Blood Adv. 2023 Dec 26;7(24):7459-7470. doi: 10.1182/bloodadvances.2023010402. Blood Adv. 2023. PMID: 37552496 Free PMC article.
Melphalan Febrile Neutropenia Risk Factors.
Yasuda M, Tachi T, Osawa T, Fujii S, Inoue S, Watanabe H, Makino T, Nagaya K, Morita M, Tanaka K, Tanaka Y, Aoyama S, Teramachi H, Kasahara S, Mizui T. Yasuda M, et al. Among authors: fujii s. Gan To Kagaku Ryoho. 2023 Jun;50(6):707-711. Gan To Kagaku Ryoho. 2023. PMID: 37317605
3,711 results